buflomedil has been researched along with Cerebrovascular Disorders in 11 studies
buflomedil: RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventy-six patients took part in a randomized, comparative study of the efficacy of buflomedil hydrochloride and dihydrogenated ergot alkaloids in the treatment of senile dementia associated with cerebrovascular insufficiency." | 9.05 | The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids. ( Bruckner, GW; Jansen, P; Jansen, W, 1985) |
| "Buflomedil hydrochloride is a vasoactive drug with a variety of pharmacodynamic properties." | 7.76 | Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. ( Clissold, SP; Lynch, S; Sorkin, EM, 1987) |
| "Buflomedil chlorhydrate is a newly synthesized molecule with a notable effect of vasodilatation even on cerebral blood vessels." | 6.66 | [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. ( Ciuffetti, G; Lombardini, R; Mercuri, M; Palazzetti, D; Parnetti, L; Rizzo, MT, 1989) |
| "Seventy-six patients took part in a randomized, comparative study of the efficacy of buflomedil hydrochloride and dihydrogenated ergot alkaloids in the treatment of senile dementia associated with cerebrovascular insufficiency." | 5.05 | The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids. ( Bruckner, GW; Jansen, P; Jansen, W, 1985) |
| "Buflomedil hydrochloride is a vasoactive drug with a variety of pharmacodynamic properties." | 3.76 | Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. ( Clissold, SP; Lynch, S; Sorkin, EM, 1987) |
| "Buflomedil chlorhydrate is a newly synthesized molecule with a notable effect of vasodilatation even on cerebral blood vessels." | 2.66 | [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. ( Ciuffetti, G; Lombardini, R; Mercuri, M; Palazzetti, D; Parnetti, L; Rizzo, MT, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaha, L | 1 |
| Dubourg, A | 1 |
| Scamuffa, RF | 1 |
| Demichelis Genesio, MA | 1 |
| Sanz, MC | 1 |
| Pacheco e Silva, A | 1 |
| Landi de Almedia, AM | 1 |
| Lombardini, R | 2 |
| Ciuffetti, G | 2 |
| Paltriccia, R | 1 |
| Scarponi, AM | 1 |
| Savastano, V | 1 |
| Palazzetti, D | 2 |
| Mercuri, M | 2 |
| Parnetti, L | 2 |
| Rizzo, MT | 1 |
| Bossi, E | 1 |
| Bossi, L | 2 |
| Clissold, SP | 1 |
| Lynch, S | 1 |
| Sorkin, EM | 1 |
| Jansen, W | 1 |
| Bruckner, GW | 1 |
| Jansen, P | 1 |
| Salerno, L | 1 |
| Sallì, L | 1 |
| Pepe, S | 1 |
| Curiale, B | 1 |
| Allegra, G | 1 |
| Scalici, G | 1 |
| Salvato, F | 1 |
2 reviews available for buflomedil and Cerebrovascular Disorders
| Article | Year |
|---|---|
An experimental overview of a new vasoactive drug: buflomedil HCl.
Topics: Animals; Cerebrovascular Disorders; Chronic Disease; Coronary Disease; Dogs; Hemodynamics; Humans; I | 1981 |
Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
Topics: Adult; Aged; Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Kinetics; Pyrroli | 1987 |
7 trials available for buflomedil and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Monitoring therapy in the treatment of cerebrovascular insufficiency].
Topics: Bencyclane; Cerebrovascular Disorders; Cinnarizine; Double-Blind Method; Humans; Nicergoline; Pyrrol | 1983 |
Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency.
Topics: Aged; Aging; Cerebrovascular Disorders; Clinical Trials as Topic; Ergot Alkaloids; Female; Hemodynam | 1981 |
Double blind comparative study of cinnarizine and buflomedil in patients suffering from cerebrovascular insufficiency.
Topics: Aged; Blood Pressure; Cerebrovascular Disorders; Cholesterol; Cinnarizine; Double-Blind Method; Fema | 1981 |
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
Topics: Aged; Cerebrovascular Disorders; Chronic Disease; Clinical Trials as Topic; Erythrocyte Deformabilit | 1989 |
Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
Topics: Adult; Aged; Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Kinetics; Pyrroli | 1987 |
The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Dementia; Dihydroergotoxine; Female; Huma | 1985 |
[Stroke and post-ictal states].
Topics: Brain Edema; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Clinical Trials as Topi | 1985 |
3 other studies available for buflomedil and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
Topics: Aged; Blood Viscosity; Cerebrovascular Disorders; Chronic Disease; Erythrocyte Deformability; Female | 1989 |
[Acute and chronic cerebrovascular diseases. A therapeutic approach].
Topics: Brain; Brain Ischemia; Cerebrovascular Disorders; Electroencephalography; Humans; Pyrrolidines; Tomo | 1989 |
[Treatment of chronic cerebrovascular insufficiency and chronic obliterating arteriopathy of the lower extremities with buflomedil hydrochloride].
Topics: Aged; Anorexia; Arteriosclerosis Obliterans; Cerebrovascular Disorders; Drug Tolerance; Female; Head | 1985 |